MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Managed Care
September 2003
William Silverman
Is Selective Use of Palivizumab Appropriate in Premature Infants? In reference to the article in the May 2003 issue of Managed Care entitled "A Health Care Management Company's Experience with Palivizumab," the assertions made by William Silverman, MD, in that article deserve comment. mark for My Articles similar articles
American Family Physician
March 1, 2003
James C. Higgins
The 'Crashing Asthmatic' Asthma is one of the most common chronic disorders managed by family physicians. A "crashing asthmatic" is a patient with asthma who is clinically deteriorating into respiratory failure or arrest despite initial treatment. Managing such a patient can be a major challenge. mark for My Articles similar articles
Managed Care
January 2002
William Silverman
A Health Care Management Company's Experience with Palivizumab On June 19, 1998, the Food and Drug Administration licensed palivizumab, as the first monoclonal antibody introduced into clinical practice for the prevention of an infectious disease, respiratory syncytial virus (RSV) disease... mark for My Articles similar articles
American Family Physician
September 1, 2004
Ostapchuk, Roberts & Haddy
Community-Acquired Pneumonia in Infants and Children When diagnosing community-acquired pneumonia, physicians should rely mainly on the patient's history and physical examination, supplemented by judicious use of chest radiographs and laboratory tests as needed. mark for My Articles similar articles
American Family Physician
February 15, 2003
Antiviral Drugs in the Immunocompetent Host: Part II. Treatment of Influenza and Respiratory Syncytial Virus Infections mark for My Articles similar articles
Managed Care
May 2003
William Silverman
A Health Care Management Company's Experience With Palivizumab - 1 Year Later The appropriate application of criteria for the use of palivizumab can save health plans a significant amount of money. mark for My Articles similar articles
American Family Physician
November 1, 2002
Hashim & Guillet
Common Issues in the Care of Sick Neonates Some newborn infants require observation and care that is beyond the scope of a normal newborn nursery. In many hospitals, this level of care is designated intermediate, level II, or special care nursery. Infants in these nurseries may be managed by family physicians... mark for My Articles similar articles
American Family Physician
October 1, 2001
Michael Luszczak
Evaluation and Management of Infants and Young Children with Fever Acute febrile illness in an infant or a young child is a common clinical scenario that can be a diagnostic challenge. The evaluation is guided by the history and physical examination, along with judiciously selected screening tests... mark for My Articles similar articles
American Family Physician
May 15, 2002
Alex H. Krist & Amy Crawford-Faucher
Management of Newborns Exposed to Maternal HIV Infection The management of infants whose mothers are infected with the human immunodeficiency virus involves minimizing the risk of vertical transmission of HIV, recognizing neonatal HIV infection early, preventing opportunistic infections, and addressing psychosocial issues... mark for My Articles similar articles
The Motley Fool
February 29, 2008
Brian Orelli
RNAi Works -- Maybe Alnylam presents the first proof of concept that RNAi works in humans, but where's the proof that it cures a disease? mark for My Articles similar articles
American Family Physician
March 1, 2006
Robert C. Langan
Discharge Procedures for Healthy Newborns Physicians should use a checklist to facilitate discussions with new parents before discharging their healthy newborn from the hospital. The checklist should include information on breastfeeding, warning signs of illness, and ways to keep the child healthy and safe. mark for My Articles similar articles
The Motley Fool
June 9, 2009
Brian Orelli
Alnylam Lays Down a Sacrifice Bunt RNAi is still an unproven technology, and there's plenty of chances for it to strike out. mark for My Articles similar articles
The Motley Fool
August 31, 2010
Brian Orelli
A Mostly Meaningless FDA Rejection The Food and Drug Administration sends AstraZeneca back to the drawing board for the second time when it rejected motavizumab, the drugmaker's newest treatment for respiratory syncytial virus. mark for My Articles similar articles